Varenicline Maltose Adduct Impurity

Varenicline Maltose Adduct Impurity

CAT No VV-V001053
CAS No NA
Mol.F. C25H33N3O10
Mol.Wt. 535.6

Chemical Name: (3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Shipping Temperature: Ambient

Country of Origin: India

Smiles: O[C@H]1[C@H](O)[C@@H](CO)OC(O[C@H]2[C@H](O)[C@@H](O)[C@H](N3CC4C5=CC6=NC=CN=C6C=C5C(C4)C3)O[C@@H]2CO)[C@@H]1O

Varenicline Maltose Adduct Impurity is chemically (3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-(6,7,9,10-tetrahydro-8H-6,10-methanoazepino[4,5-g]quinoxalin-8-yl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. Varenicline Maltose Adduct Impurity is supplied with detailed characterization data compliant with regulatory guideline. Varenicline Maltose Adduct Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Varenicline.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.